No insider purchase over the last 90 days. The latest was filed 20 Nov 2025.
Convalue SE, classified in the Finance & Banking sector, is a listed company. Its insiders report their share dealings to BaFin. Over the twelve months to 18 October 2026, 1 filing were filed, from 1 insider.
Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase totalling €108k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €108k, bought by Priamos Beteiligungen AG and made public on 20 November 2025.
Compared with its exchange (287 companies, median 5 filings), a count of 1 filing is below the norm. Since 2025, the database holds 2 purchases and no sales by insiders of the company.
The most recent open-market purchase was published on 20 November 2025, 331 days ago.
Elsewhere in the same sector, our signals recently picked up insider purchases at First Guaranty Bancshares, Inc. and BCB Bancorp Inc. Source: insider filings from BaFin. Past trades are no guide to future returns.
· cache
2 of 2 declarations
ConValue SE is a German listed investment company, with market reporting tied to the German regulatory framework for MAR Article 19 director dealings and the associated BaFin disclosure environment. The shares are referenced in the context of the Xetra/Frankfurt ecosystem (DAX/MDAX/SDAX), while the stock itself is admitted to trading in the open market in Berlin and Düsseldorf. For investors, the name should be understood as an investment vehicle rather than a traditional operating industrial business. ([convalue.se](https://convalue.se/investoren/))
ConValue SE is structured as a Societas Europaea (SE), headquartered in Frankfurt, Germany, with contact details in Hamburg. Its business model is centered on allocating capital into equities, with a clear focus on the DACH region and on globally invested equity funds. The company explicitly presents itself as a value-oriented investor: it favors businesses that can compound shareholder value over the long term, offer attractive reinvestment opportunities for free cash flow, and are led by management teams that historically treat shareholders as genuine partners. ([convalue.se](https://convalue.se/investoren/))
The company’s recent corporate history includes a fully subscribed cash capital increase completed in 2021, which brought share capital to EUR 16.75 million divided into 16.75 million no-par bearer shares with a nominal value of EUR 1 each. This is a useful structural detail for equity investors because it highlights a straightforward capital structure and a shareholder base that supported the expansion. ConValue also states that the board and supervisory board together hold a significant shareholding, with more than 50% of the shares owned by the corporate bodies, implying strong internal alignment but also a relatively limited free float. ([convalue.se](https://convalue.se/investoren/))
On portfolio positioning, ConValue SE reports exposures across global equities, predominantly U.S. equities, and European equities. Among the notable holdings disclosed are MLP SE, Jungfraubahn, Nu Holdings, Allianz, KSB preferred shares, HT5, MTU Aero Engines, La Française de l’Énergie, Heidelberg Materials, Acacia Research, and LEG SE. This indicates a concentrated but diversified, fundamentally driven portfolio with a pronounced tilt toward quality mid caps and selected special situations. ([convalue.se](https://convalue.se/investoren/))
Geographically, the company is primarily anchored in Germany and Europe, but its investment universe is international through U.S. equities and global funds. The 2024 half-year report shows that ConValue operates with financial assets, cash balances, and market-driven earnings dynamics rather than recurring operating revenue in the conventional sense. It also documents active portfolio management, including the complete disposal of LEG Immobilien SE and TAG Immobilien AG at gains, which underlines a disciplined, opportunistic approach to capital allocation. ([convalue.se](https://convalue.se/wp-content/uploads/2024/09/2024_30.06._ConValue_SE_Halbjahresbericht.pdf))
A recent noteworthy item is the July 2025 MAR Article 19 disclosure concerning a director-related purchase of ConValue shares, confirming ongoing regulatory transparency around management dealings. For investors, the central analytical questions remain the quality of stock selection, valuation discipline, and the company’s ability to preserve and grow net asset value through market cycles. ([boerse-frankfurt.de](https://www.boerse-frankfurt.de/nachrichten/Convalue-SE-Mitteilung-ueber-Eigengeschaefte-von-Fuehrungskraeften-gemaess-Artikel-19-MAR-3c22d24b-4ce6-4841-a54f-5b1273b32c7f?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendations